Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 2;1(4):e30.
doi: 10.1002/puh2.30. eCollection 2022 Dec.

Travel-related gastrointestinal diseases: Assessment and management

Dominic Butler  1 , Ramona McLoughlin  1   2 , Gerard T Flaherty  1   3
Affiliations
Review

Travel-related gastrointestinal diseases: Assessment and management

Dominic Butler et al. Public Health Chall. .

Abstract

Introduction: Gastrointestinal illnesses are among the most common health problems affecting travellers returning from international travel. Its public health implications include economic healthcare costs and the risk of promoting antimicrobial resistance. This narrative review aims to critically appraise the literature concerning gastrointestinal diseases in travellers and outlines a practical approach to aid clinicians in their assessment and management.

Methods: The Medline (PubMed) and SCOPUS databases were searched for articles relating to gastrointestinal issues in returning travellers. Articles were primarily restricted to those published in the last 5 years. Only studies on human subjects were included.

Results: Diarrhoea is the most common gastrointestinal symptom experienced by approximately 40%-60% of travellers, but abdominal pain, bloating and fatigue are also common. Diarrhoeagenic Escherichia coli species remain the most common cause of travellers' diarrhoea (TD), with parasitic diseases predominating in those with persistent symptoms. Molecular diagnostic techniques enable highly sensitive simultaneous testing for a multitude of enteropathogens, though more research is required to confirm the pathogenic significance of organisms identified. Further research into poorly absorbable antibiotics and novel therapies such as phage treatment may help to alleviate the burden of antimicrobial resistance. There is a role for empirical anti-parasitic therapy in selected cases.

Conclusion: Clinicians across a range of medical specialities should be familiar with the presentation, aetiology and management of gastrointestinal illness in the returning traveller. Efforts to improve destination sanitation and hygiene infrastructure may serve to reduce the burden of preventable illness in this setting.

Keywords: persistent abdominal symptoms; travel health; travellers’ diarrhoea.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

FIGURE 1
FIGURE 1
An approach to returning travellers with abdominal symptoms, with a focus on bacterial TD.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Harvey K, Esposito DH, Han P, et al. Surveillance for travel‐related disease–GeoSentinel surveillance system, United States, 1997–2011. MMWR Surveill Summ. 2013;62:1‐23. - PubMed
    1. Nissan B, Lachish T, Schwartz E. The effectiveness of empirical anti‐parasitic treatment in returning travellers with persistent abdominal symptoms. J Travel Med. 2018;25(1):1‐7. - PubMed
    1. Lever RA, Tapper L, Skarbek S, Chiodini PL, Armstrong M, Bailey RL. Predictors of aetiology and outcomes of acute gastrointestinal illness in returning travellers: a retrospective cohort analysis. BMC Infect Dis. 2021;21(1):599. - PMC - PubMed
    1. Organisation WH. Diarrhoeal Disease 2017. Available from: Diarrhoeal disease (who.int).
    1. Ferrah N, Leder K, Gibney K. Review of the causes and management of chronic gastrointestinal symptoms in returned travellers referred to an Australian infectious diseases service. Aust Fam Physician. 2016;45(5):333‐339. - PubMed

LinkOut - more resources